Literature DB >> 17936081

Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease.

Jacqueline Lee1, Angela Anggiansah, Roy Anggiansah, Alasdair Young, Terry Wong, Mark Fox.   

Abstract

BACKGROUND & AIMS: The prevalence of complicated gastroesophageal reflux disease (GERD) increases with age; however, the mechanism by which this occurs is uncertain. This study assessed (1) whether physiologic degradation of the gastroesophageal junction and esophageal motility occurs with aging, and (2) whether these effects are associated with increased esophageal acid exposure and reflux symptoms in the elderly.
METHODS: Retrospective study of 1307 patients referred for investigations of reflux symptoms (median age, 49 years; range, 15-92 years) was conducted. Manometry assessed LES pressure, LES length, and esophageal peristalsis. Ambulatory pH studies assessed esophageal acid exposure (% time pH <4) during a period of 24 hours; reflux symptoms were assessed by validated questionnaire.
RESULTS: On multivariate regression, esophageal acid exposure was associated independently with decreasing LES pressure (P < .0001) and abdominal LES length (P < .0004). Dysmotility exacerbated reflux in the recumbent position (P < .004). Acid exposure increased with age (P < .0001), a 1.1%/24 hours (95% confidence interval, 0.4%-1.4%) increase in acid exposure every decade (more pronounced in the recumbent position). The age-related increase in acid exposure was associated independently with decreasing abdominal LES length (P < .001) and increasing dysmotility (P < 0.01). Reflux symptoms increased with acid exposure (P < .001); however, at any given level of exposure, symptom severity was less in the elderly (P < .006).
CONCLUSIONS: Age was associated with an increase in esophageal acid exposure; however, the severity of reflux symptoms reduced with age. These changes were associated with progressive decrease in abdominal LES length and esophageal motility. Increasing GERD severity in the elderly is related to degradation of the gastroesophageal junction and impaired esophageal clearance.

Entities:  

Mesh:

Year:  2007        PMID: 17936081     DOI: 10.1016/j.cgh.2007.08.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  36 in total

1.  Laryngopharyngeal reflux in patients with reflux esophagitis.

Authors:  Yung-Chih Lai; Pa-Chun Wang; Jun-Chen Lin
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 2.  What Is the Impact of High-Resolution Manometry in the Functional Diagnostic Workup of Gastroesophageal Reflux Disease?

Authors:  Jutta Keller
Journal:  Visc Med       Date:  2018-04-12

3.  Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats.

Authors:  Takahiro Masuda; Fumiaki Yano; Nobuo Omura; Kazuto Tsuboi; Masato Hoshino; Se Ryung Yamamoto; Shunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2017-11-15       Impact factor: 3.199

4.  Normal Values of High-Resolution Manometry in Supine and Upright Positions in a Thai Population.

Authors:  Pitichote Hiranyatheb; Suriya Chakkaphak; Supphamat Chirnaksorn; Pattaraporn Lekhaka; Kaimuk Petsrikun; Kornkanok Somboonpun
Journal:  Dig Dis Sci       Date:  2017-11-15       Impact factor: 3.199

5.  Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.

Authors:  David R Braxton; Dana C Nickleach; Yuan Liu; Alton B Farris
Journal:  Virchows Arch       Date:  2014-05-27       Impact factor: 4.064

Review 6.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 7.  Environmental - lifestyle related factors.

Authors:  Sabine Roman; John E Pandolfino
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

8.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

Review 9.  Management of Gastroesophageal Reflux Disease in the Elderly Patient.

Authors:  Michael Kurin; Ronnie Fass
Journal:  Drugs Aging       Date:  2019-12       Impact factor: 3.923

10.  Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease.

Authors:  M D Mello; A R Shriver; Y Li; A Patel; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2015-11-17       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.